Old Web
English
Sign In
Acemap
>
authorDetail
>
Yoshikazu Nezu
Yoshikazu Nezu
Daiichi Sankyo
Endocrinology
Internal medicine
Biology
Skeletal muscle
Cerivastatin
4
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Plasma 2-hydroxyglutarate, a promising prognostic biomarker candidate for skeletal muscle injury in Fischer 344 rats
2018
Journal of Toxicological Sciences
Hisakuni Obayashi
Naoko Kobayashi
Yoshikazu Nezu
Takashi Yamoto
Mitsuyuki Shirai
Fumitoshi Asai
Show All
Source
Cite
Save
Citations (0)
Plasma 2-hydroxyglutarate and hexanoylcarnitine levels are potential biomarkers for skeletal muscle toxicity in male Fischer 344 rats
2017
Journal of Toxicological Sciences
Hisakuni Obayashi
Naoko Kobayashi
Yoshikazu Nezu
Takashi Yamoto
Mitsuyuki Shirai
Fumitoshi Asai
Show All
Source
Cite
Save
Citations (2)
R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model.
2014
European Journal of Pharmacology
Hideki Terashima
Mikio Kato
Masayuki Ebisawa
Hideki Kobayashi
Kanae Suzuki
Yoshikazu Nezu
Toshio Sada
Show All
Source
Cite
Save
Citations (11)
Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats
2011
Journal of Toxicological Sciences
Hisakuni Obayashi
Yoshikazu Nezu
Hatsue Yokota
Naoki Kiyosawa
Kazuhiko Mori
Naoyuki Maeda
Yoshiro Tani
Sunao Manabe
Atsushi Sanbuissho
Show All
Source
Cite
Save
Citations (19)
1